mRNA cancer – Talk Bio

Spotlight On: Five key oncology stories to watch in 2026

3 weeks ago talkbio0Tagged 2026, Antibody-Drug Conjugates, cancer research trends, CAR-T, Cell Therapy, Liquid Biopsy, Lymphocytes, Tumor-Infiltrating, mRNA cancer, Neoplasms, oncology decisions, precision oncology, Radiopharmaceuticals, T-Cell Receptor, United States Food and Drug Administration, Vaccines

oncology 2026; cancer research trends; FDA oncology decisions 2026; antibody-drug conjugates; radiopharmaceuticals; liquid biopsy; mRNA cancer vaccines; AI in oncology; cell therapies CAR-T TIL TCR; precision oncology

Strand Therapeutics Raises $153M Series B to Advance mRNA Tumor Drugs

6 months ago talkbio0Tagged Big Pharma investors, biotech financing, Clinical Trials, Genomic Orientation, interleukin-12, mRNA cancer, Series B funding, Solid Neoplasm, STX-001

Strand Therapeutics; Series B funding; mRNA cancer therapy; STX-001; IL-12; solid tumors; Big Pharma investors; clinical trial results; biotech financing

BioNTech and Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma

1 year ago talkbio0Tagged BioNTech, cemiplimab, Libtayo, melanoma, mRNA cancer, Phase 2 Clinical Trials, Regeneron, Tetravalent RNA-lipoplex Cancer Vaccine BNT111, Vaccines

BioNTech, Regeneron, mRNA cancer vaccine, Phase II trial, melanoma, BNT111, cemiplimab, Libtayo